Claims for Patent: 8,759,306

Summary for Patent: 8,759,306

Title:	RNAi for the control of insects and arachnids
Abstract:	The present invention describes a new non-compound based approach for insect and/or arachnid control. The present inventors have identified for the first time novel targets for RNAi, which can effectively control insect and/or arachnid pest populations. Accordingly, the invention provides both nucleotide and amino acid sequences for the novel targets. Also provided are RNA constructs including double stranded RNA regions for mediating RNAi in insects, DNA constructs, expression vectors, host cells and compositions for controlling insects and/or arachnids using RNAi. Finally, the invention also provides for the use of the constructs, vectors, host cells and compositions in control of insects and/or arachnids populations and suitable kits for use in an RNAi based method of controlling insect and/or arachnid pests.
Inventor(s):	Kaletta; Titus Jan (Klein-Winternheim, DE)
Assignee:	Devgen N.V. (Zwijnaarde, BE)
Application Number:	11/921,370
Patent Claims:	1. An RNA construct comprising at least one double stranded RNA region, at least one strand of which comprises a nucleotide sequence that is complementary to at least 24 nucleotides of a nucleotide sequence as set forth in any one of SEQ ID NOs: 1, 6, 9, 10, 65 to 70, 73 to 76 and 78, or the complement thereof, or an orthologous nucleotide sequence from a Blattodea species, wherein the orthologous nucleotide sequence has at least 80% sequence identity with the nucleotide sequence of SEQ ID NO: 1, wherein the percentage sequence identity is calculated over the same length. 2. The RNA construct according to claim 1 wherein the complementarity of said nucleotide sequence comprises at least 95% nucleotide sequence identity with (i) at least 25 nucleotides of any one of the nucleotide sequences as defined in claim 1, or the complement thereof, wherein the percentage sequence identity is calculated over the same length. 3. The RNA construct according to claim 1 wherein the nucleotide sequence comprised in the at least one strand has less than 12.5% sequence identity over 24 contiguous nucleotides with the corresponding nucleotide sequence from a mammalian species. 4. The RNA construct according to claim 1 comprising at least two nucleotide sequences independently chosen from any of SEQ ID NOs 1, 6, 9, 10, 65 to 70, 73 to 76 and 78, for instance any of SEQ ID NOs 65 to 70. 5. The RNA construct of claim 1 which comprises at least one additional dsRNA region, at least one strand of which comprises a nucleotide sequence that is complementary to at least 21 nucleotides of the nucleotide sequence of a further gene from a Blattodea species. 6. The RNA construct according to claim 5 wherein the complementarity of said nucleotide sequence comprises at least 70% nucleotide sequence identity, wherein the percentage sequence identity is calculated over the same length. 7. The RNA construct according to claim 5 wherein the at least one strand has less than 12.5% sequence identity over 24 contiguous nucleotides with the corresponding nucleotide sequence from a mammalian species. 8. The RNA construct according to claim 7, wherein the mammalian species is a human. 9. The RNA construct of claim 1, further comprising at least one additional functional sequence and optionally a linker. 10. The RNA construct according to claim 9 wherein said additional functional sequence is a sequence facilitating large-scale production of the RNA construct. 11. The RNA construct according to claim 9 wherein the linker is a conditionally self-cleaving RNA sequence, optionally a pH sensitive linker or a hydrophobic sensitive linker. 12. The RNA construct according to claim 9 wherein the linker is an intron. 13. The RNA construct according to claim 9 wherein said additional functional sequence is a sequence effecting an increase or decrease in the stability of the dsRNA. 14. The RNA construct according to claim 9 wherein said additional functional sequence is a sequence allowing the binding of proteins or other molecules to facilitate uptake of the RNA construct by a Blattodea. 15. The RNA construct according to claim 9 wherein said additional functional sequence is a sequence which is an aptamer that binds to receptors or to molecules in the gut of an insect to facilitate uptake, endocytosis and/or transcytosis by Blattodea. 16. The RNA construct according to claim 1 wherein the at least one strand comprises at least 27 nucleotides or more of any of the nucleic acid molecules comprising the nucleotide sequence as set forth in any of SEQ ID NOs 1, 9, 10, 65 to 70, 74 and 75, or the complement thereof. 17. A DNA construct comprising a nucleotide sequence encoding an RNA construct of claim 1. 18. An expression construct comprising a DNA construct according to claim 17. 19. An expression construct according to claim 18 further comprising one or more control sequences capable of driving expression of the nucleotide sequence; and optionally a transcription termination sequence. 20. A host cell comprising an RNA construct of claim 1. 21. The host cell as defined in claim 20, which is a bacterial cell. 22. The host cell as defined in claim 21, which is an inactivated bacterial cell. 23. A pesticide composition comprising an RNA construct as defined in claim 1 together with a suitable carrier. 24. The composition according to claim 23 wherein the carrier comprises electrostatically charged powder or particles and/or magnetic particles, preferably metallic particles which are initially unmagnetised but which are capable of becoming magnetically polarised when subjected to the electrical field provided by the Blattodea body, which powder or particles adhere to the Blattodea cuticle and which may be ingested by a Blattodea. 25. The composition of claim 23 in combination with a further pesticide. 26. A housing or trap for Blattodea which contains a composition as defined in claim 23. 27. A kit comprising the RNA construct of claim 1 and instructions for using the RNA construct. 28. The kit of claim 27 which comprises multiple RNA constructs, wherein each double stranded RNA is capable of down regulating the expression of at least one Blattodea gene through RNA interference. 29. The kit of claim 27 wherein the multiple RNA constructs are used sequentially in order to reduce the probability of the Blattodea acquiring resistance. 30. A method of controlling Blattodea comprising administering to the Blattodea an RNA construct as defined in claim 1, wherein the double stranded RNA is capable of down regulating the expression of at least one Blattodea gene through RNA interference. 31. The method of claim 30, wherein multiple RNA constructs are administered to said Blattodea. 32. The method of claim 31, wherein the multiple RNA constructs are administered sequentially in order to reduce the probability of the Blattodea acquiring resistance. 33. The method according to claim 30, wherein the Blattodea is a Blatella spp., Periplaneta spp., Blatta spp. or Supella spp. 34. A method for controlling cockroach pests comprising providing to the cockroach an RNA construct comprising at least one double stranded RNA region, at least one strand of which comprises a nucleotide sequence that is complementary to at least 21 nucleotides of a nucleotide sequence as set forth in any of SEQ ID NOs 1, 6, 9, 10, 65-70, 73 to 76 and 78, or the complement thereof. 35. The method according to claim 24 wherein said cockroach pest is chosen from the species belonging to the group of genera consisting of Blatella, Periplaneta, Blatta and Supella. 36. A method according to claim 34 wherein said cockroach pest is chosen from the group consisting of German cockroach (Blatella Germanica), American cockroach (Periplaneta americana), Australian cockroach (Periplaneta australiasiae), Oriental cockroach (Blatta orientalis) and brown-banded cockroach (Supella longipalpa). 37. An RNA construct comprising at least one double stranded RNA region, at least one strand of which comprises at least 24 nucleotides or more of any of the nucleic acid molecules comprising the nucleotide sequence as set forth in any of SEQ ID NOs 1, 6, 9, 10, 65 to 70, 73 to 76 and 78, or the complement thereof. 38. A DNA construct comprising a region encoding an RNA construct of claim 5. 39. An expression construct comprising a DNA construct according to claim 38. 40. A host cell comprising an RNA construct of claim 5 or an expression construct of claim 39. 41. The host cell as defined in claim 40, which is a bacterial cell. 42. The host cell as defined in claim 41, which is an inactivated bacterial cell. 43. A pesticide composition comprising the host cell of claim 41. 44. The composition according to claim 43, which is in the form of a bait. 45. The composition according to claim 43, which is in the form of a spray, preferably a pressurized/aerosolized spray or pump spray. 46. A method for generating an RNA construct, comprising contacting a DNA construct of claim 17 with cell-free components under conditions that allow transcription of said DNA construct to produce said RNA construct. 47. The method of claim 46 wherein the cell is a bacterial cell. 48. A pesticide composition comprising an RNA construct as defined in claim 5 together with a suitable carrier. 49. The composition according to claim 48 which is in a form suitable for ingestion by a Blattodea species. 50. The composition according to claim 48 which is in solid form, such as a pellet or powder, liquid form or gel form. 51. The composition according to claim 48 which is in the form of a bait. 52. The composition according to claim 51 wherein the bait further includes at least one food substance, such as a protein based food or boric acid and/or an attractant, such as a pheromone. 53. The composition according to claim 48 wherein the composition is stored in a housing or trap which a Blattodea species can enter in order to ingest the composition. 54. The composition according to claim 48 which is in the form of a spray, preferably a pressurized/aerosolized spray or a pump spray. 55. The composition according to claim 48 which is in the form of a coating on a suitable surface which adheres to an insect and/or arachnid when it comes into contact with the coating. 56. The composition according to claim 48 wherein the carrier comprises electrostatically charged powder or particles and/or magnetic particles, preferably metallic particles which are initially unmagnetised but which are capable of becoming magnetically polarised when subjected to the electrical field provided by the Blattodea body, which adhere to the Blattodea cuticle. 57. The composition according to claim 48 wherein the carrier increases the uptake of the double stranded RNA into the Blattodea. 58. The composition of claim 57 wherein the carrier is a lipid-based carrier, preferably comprising one or more of, oil-in water emulsions, cholesterol, micelles, lipopolyamines and liposomes. 59. The composition of claim 57 wherein the carrier comprises a nucleic acid condensing agent, preferably spermidine or protamine sulphate. 60. A housing or trap for Blattodea species which contains a composition as defined in claim 48. 61. A method of controlling Blattodea species comprising administering to a Blattodea species an RNA construct as defined in claim 5, wherein the double stranded RNA is capable of down regulating the expression of at least one Blattodea gene through RNA interference. 62. The method of claim 61, wherein multiple RNA constructs are administered. 63. The method of claim 62, wherein the multiple RNA constructs are administered sequentially in order to reduce the probability of the pest acquiring resistance. 64. The method according to claim 61, wherein the Blattodea species is Blatella spp., Periplaneta spp., Blatta spp. or Supella spp. 65. The method according to claim 61 wherein the Blattodea species is growth delayed, paralysed, made infertile or killed. 66. A kit comprising the RNA construct of claim 5 and instructions for using the double stranded RNA construct. 67. The kit of claim 66 which comprises multiple RNA constructs, wherein each double stranded RNA is capable of down regulating the expression of at least one Blattodea gene through RNA interference. 68. The kit of claim 67 wherein the multiple RNA constructs are used sequentially in order to reduce the probability of the Blattodea acquiring resistance. 69. A method for generating an RNA construct, comprising culturing a host cell as defined in claim 20 under conditions that permit expression of the RNA construct. 70. The method of claim 69 further comprising purification of the RNA construct. 71. An expression construct comprising a DNA construct encoding the RNA construct of claim 1. 72. A host cell comprising the DNA construct of claim 17. 73. A pesticide composition comprising a host cell of claim 20 or claim 72 together with a suitable carrier. 74. The composition according to claim 73, which is in the form of a spray, preferably a pressurized/aerosolized spray or pump spray. 75. A method of controlling Blattodea species comprising administering to a Blattodea the host cell of claim 20 or claim 72. 76. The method of claim 75, wherein multiple host cells or compositions are administered to said Blattodea species. 77. The method of claim 76, wherein the multiple host cells or compositions are administered sequentially. 78. A method of controlling Blattodea species comprising administering to a Blattodea the host cell of claim 41, wherein the double stranded RNA is capable of down regulating the expression of at least one Blattodea gene through RNA interference. 79. The method of claim 78, wherein multiple host cells or compositions are administered to said Blattodea species. 80. A method for generating an RNA construct, comprising administering a DNA construct of claim 17 to a cell under conditions that allow transcription of said DNA construct to produce said RNA construct. 81. The method of claim 80 wherein the cell is a bacterial cell. 82. A housing or trap for Blattodea species which contains a composition as defined in claim 73. 83. A housing or trap for Blattodea species which contains the composition as defined in claim 43.

Details for Patent 8,759,306

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2025-05-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2025-05-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2025-05-31